Bridgehead Communications
Numan logo

Numan

Men's health telehealth

Patient access & engagement

London-founded men's health telehealth platform offering CQC-registered remote consultations and treatment for conditions like erectile dysfunction, hair loss and weight management.

The read

Numan offers remote consultations and ongoing treatment for men's health conditions including erectile dysfunction, hair loss and weight management, combining CQC-registered clinical assessment with home delivery of prescribed treatment.

The company closed a $60m Series B extension in 2025, backed by Big Pi Ventures alongside earlier investors White Star Capital and Novator Partners, funding continued expansion of its remote-first clinical model.

The Bridgehead view

Numan's ability to raise a Series B extension years after its original round, in a category (men's health DTC) that has seen plenty of investor caution, suggests its CQC-anchored clinical model has proven more durable than the lighter-touch wellness apps it's sometimes lumped in with.

FAQs

About this page

No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of Numan above is drawn from public reporting, not sponsored content.

We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.

Yes. If you represent Numan, or anything here looks out of date, get in touch through our contact page and we will review it.

Work with us

Building a medtech brand?

We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.

Working across the healthcare sector?

We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.

The firm that knows medtech

We map this sector because
we represent it.

Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.